View all research projects
Research project

Preclinical efficacy and safety studies of ADAM33 oligonucleotides as new disease-modifying asthma therapy

Staff

Lead researchers

Professor Hans Michael Haitchi MD, MMed(INT), PhD, PD, MRCP(London), FHEA, PGcert

Professor
Research interests
  • ÃÛÌÒTV of the asthma susceptibility gene A Disintegrin and Metalloprotease 33 (ADAM33) in earl…
  • Development of novel Anti-ADAM33 agents as potential disease modifying asthma therapy.
  • Multiomic study of the influence of the maternal environment (e.g. allergic asthma, obesity) …
Connect with Hans Michael

Email: H.M.Haitchi@soton.ac.uk

Research outputs